Furthermore, decreasing the expression of the SREBP2 gene in glioblastoma can suppress mesenchymal transformation in non-mesenchymal gliomas, thereby inhibiting tumor metastasis (Ferrarese et al., 2023). Here, SREBF2 is linked to central nervous system cancer.